#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    PIK3CA-activated mutation Prostate cancer Chronic cutaneous lupus erythematosus Short-bowel syndrome Rosai-Dorfman syndrome Juvenile idiopathic arthritis Mitochondrial myopathy Gastrointestinal cancer metastatic Palmar-plantar erythrodysaesthesia syndrome Juvenile chronic myelomonocytic leukaemia Angiosarcoma recurrent Cutaneous T-cell lymphoma stage I NTRK gene fusion overexpression Phenylketonuria Hodgkin's disease More trials…

    Learn about Rare Diseases

    Langerhans cell sarcoma – Basic Information Rhabdoid tumour – Basic Information Rhabdoid tumour – Life with Disease X-linked lymphoproliferative syndrome Andersen-Tawil syndrome – Life with Disease Hypereosinophilic syndrome – Trials in Disease Splenic marginal zone lymphoma Glomerulonephritis membranous – Basic Information Chordoma – Basic Information Atypical teratoid/rhabdoid tumour of CNS – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Selinexor Ovolecithin Ondansetron Loncastuximab Tesirine Sqy51 Aripiprazole Cagrilintide Sodium Valproate Timolol Maleate Englumafusp Alfa Emavusertib Tezacaftor Petrelintide GAXILOSE Erenumab Osimertinib Ketamine Hydrochloride Bosentan SAR444336 Remdesivir More therapies…

    Learn about Your Condition

    Menopause Neoplasm malignant Status epilepticus Cholecystitis acute Tonsillitis Cerebrovascular accident Acquired ATTR amyloidosis Chordoma Bronchitis Arteriosclerosis Bipolar I disorder Tinnitus Glycogen storage disorder Aortic valve stenosis Skin wrinkling More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Varsinais-Suomen hyvinvointialue

Varsinais-Suomen hyvinvointialue

Kiinamyllynkatu 4-8, Turku, 20520, Finland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness of dTap Vaccine in Boosting Immunity Against Diphtheria, Tetanus, and Whooping Cough in Healthcare Workers

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • TETANUS TOXOID
    Finland

  • Study of Long-term Pertussis Immunity in Children at Age 4 Years Following Maternal Vaccination During Pregnancy

    Not recruiting

    3 1 1 1
    Finland

  • Study Comparing Axatilimab to Best Available Therapy for Patients with Chronic Graft-Versus-Host Disease After Two or More Treatments

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic graft versus host disease
    Investigated Drugs:
    • Axatilimab
    Austria Belgium Czechia Finland France Germany +8

  • Study on the Effects of Cladribine on Brain Cells in Patients with Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Cladribine
    Finland

  • Study on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Apalutamide
    Austria Belgium Czechia Denmark Finland Germany +7

  • Study of venglustat tablets to reduce neuropathic and abdominal pain in patients aged 16 and older with Fabry disease who are untreated or haven’t received treatment for 6 months

    Not recruiting

    3 1
    Investigated Diseases:
    • Fabry’s disease
    Investigated Drugs:
    • Venglustat
    Austria Denmark Finland France Germany Greece +4

  • Study on Imatinib and Chemotherapy Combination for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Crisantaspase
    • Hydrocortisone Sodium Succinate
    • Pegaspargase
    Austria Belgium Czechia Denmark Finland France +6
Previous Page
1 2 3 4

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!